These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31527091)

  • 21. A Role of Effector CD
    Mahasa KJ; Ouifki R; de Pillis L; Eladdadi A
    Bull Math Biol; 2024 Jun; 86(8):89. PubMed ID: 38884815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance.
    Liu Q; Liao Q; Zhao Y
    Med Hypotheses; 2016 Feb; 87():34-9. PubMed ID: 26826638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rationale for New Checkpoint Inhibitor Combinations in Melanoma Therapy.
    Mandalà M; Tondini C; Merelli B; Massi D
    Am J Clin Dermatol; 2017 Oct; 18(5):597-611. PubMed ID: 28432648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy and Combination Strategies in Pancreatic Cancer: Current Status and Emerging Trends.
    Cheung PF; Lutz M; Siveke JT
    Oncol Res Treat; 2018; 41(5):286-290. PubMed ID: 29705789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Biomarkers for Checkpoint Blockade in Urothelial Cancer: A Systematic Review.
    Lavoie JM; Black PC; Eigl BJ
    J Urol; 2019 Jul; 202(1):49-56. PubMed ID: 30730407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis.
    Kang T; Zhu Q; Wei D; Feng J; Yao J; Jiang T; Song Q; Wei X; Chen H; Gao X; Chen J
    ACS Nano; 2017 Feb; 11(2):1397-1411. PubMed ID: 28075552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
    Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
    Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.
    Alsina M; Moehler M; Lorenzen S
    Oncol Res Treat; 2018; 41(5):266-271. PubMed ID: 29705786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy.
    Wang W; Zou W; Liu JR
    Gynecol Oncol; 2018 Oct; 151(1):1-3. PubMed ID: 30243508
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating tumor-associated neutrophils (cTAN) contribute to circulating tumor cell survival by suppressing peripheral leukocyte activation.
    Zhang J; Qiao X; Shi H; Han X; Liu W; Tian X; Zeng X
    Tumour Biol; 2016 Apr; 37(4):5397-404. PubMed ID: 26563367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of the immune system in cancer: from tumor initiation to metastatic progression.
    Gonzalez H; Hagerling C; Werb Z
    Genes Dev; 2018 Oct; 32(19-20):1267-1284. PubMed ID: 30275043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophils in Cancer immunotherapy: friends or foes?
    Huang X; Nepovimova E; Adam V; Sivak L; Heger Z; Valko M; Wu Q; Kuca K
    Mol Cancer; 2024 May; 23(1):107. PubMed ID: 38760815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.
    Elia AR; Grioni M; Basso V; Curnis F; Freschi M; Corti A; Mondino A; Bellone M
    Clin Cancer Res; 2018 May; 24(9):2171-2181. PubMed ID: 29490991
    [No Abstract]   [Full Text] [Related]  

  • 34. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
    BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors.
    Hargadon KM; Johnson CE; Williams CJ
    Int Immunopharmacol; 2018 Sep; 62():29-39. PubMed ID: 29990692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When neutrophils meet T cells: beginnings of a tumultuous relationship with underappreciated potential.
    Kalyan S; Kabelitz D
    Eur J Immunol; 2014 Mar; 44(3):627-33. PubMed ID: 24435886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRPM2 Mediates Neutrophil Killing of Disseminated Tumor Cells.
    Gershkovitz M; Caspi Y; Fainsod-Levi T; Katz B; Michaeli J; Khawaled S; Lev S; Polyansky L; Shaul ME; Sionov RV; Cohen-Daniel L; Aqeilan RI; Shaul YD; Mori Y; Karni R; Fridlender ZG; Binshtok AM; Granot Z
    Cancer Res; 2018 May; 78(10):2680-2690. PubMed ID: 29490946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition.
    Hegde PS; Karanikas V; Evers S
    Clin Cancer Res; 2016 Apr; 22(8):1865-74. PubMed ID: 27084740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biliary Tract Cancer: Implicated Immune-Mediated Pathways and Their Associated Potential Targets.
    Tariq NU; Vogel A; McNamara MG; Valle JW
    Oncol Res Treat; 2018; 41(5):298-304. PubMed ID: 29705791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Biological Principles of Metastasis.
    Lambert AW; Pattabiraman DR; Weinberg RA
    Cell; 2017 Feb; 168(4):670-691. PubMed ID: 28187288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.